Dow Jones

39,869.38

-0.10%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

ISR

IsoRay (ISR)

IsoRay Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:ISR

1 2 3 4 5 6 7 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
15/05/2024	06:02	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:ISR	IsoRay Inc
24/04/2024	15:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:ISR	IsoRay Inc
19/04/2024	15:05	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	AMEX:ISR	IsoRay Inc
18/04/2024	15:11	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	AMEX:ISR	IsoRay Inc
18/04/2024	15:09	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	AMEX:ISR	IsoRay Inc
09/04/2024	23:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	AMEX:ISR	IsoRay Inc
09/04/2024	15:25	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	AMEX:ISR	IsoRay Inc
08/04/2024	15:12	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	AMEX:ISR	IsoRay Inc
01/04/2024	06:46	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	AMEX:ISR	IsoRay Inc
29/03/2024	06:35	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	AMEX:ISR	IsoRay Inc
28/03/2024	07:34	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	AMEX:ISR	IsoRay Inc
18/03/2024	15:18	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	AMEX:ISR	IsoRay Inc
08/03/2024	10:22	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	AMEX:ISR	IsoRay Inc
05/02/2024	18:18	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	AMEX:ISR	IsoRay Inc
01/02/2024	06:56	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:ISR	IsoRay Inc
01/02/2024	06:38	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	AMEX:ISR	IsoRay Inc
18/01/2024	15:49	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	AMEX:ISR	IsoRay Inc
17/01/2024	12:40	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	AMEX:ISR	IsoRay Inc
14/11/2023	15:59	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:ISR	IsoRay Inc
14/06/2023	15:46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ISR	IsoRay Inc
14/06/2023	15:42	Edgar (US Regulatory)	Specialized Disclosure Report (sd)	AMEX:ISR	IsoRay Inc
15/05/2023	16:23	Edgar (US Regulatory)	Quarterly Report (10-q)	AMEX:ISR	IsoRay Inc
15/05/2023	16:16	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:ISR	IsoRay Inc
01/05/2023	16:04	Edgar (US Regulatory)	Annual Transition Report (10-kt)	AMEX:ISR	IsoRay Inc
17/03/2023	16:09	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	AMEX:ISR	IsoRay Inc
08/03/2023	06:30	GlobeNewswire Inc.	Perspective Therapeutics Announces the Awarding of a $1 million Collaborative Grant to King’s College London to Support Radiobiology Research of Alpha Particle Therapy for Cancer	AMEX:ISR	IsoRay Inc
22/02/2023	16:02	GlobeNewswire Inc.	Initial Results From First Patient Dosed With Perspective Therapeutics’ Lead Drug VMT-α-NET Presented at The Treatment of Neuroendocrine Disorders at the 2023 PET/RTRC Annual Workshop Scientific Session	AMEX:ISR	IsoRay Inc
21/02/2023	05:02	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	AMEX:ISR	IsoRay Inc
16/02/2023	15:05	GlobeNewswire Inc.	Perspective Therapeutics (formerly known as Isoray, Inc.) Announces Financial Results for the Quarter ended December 31, 2022	AMEX:ISR	IsoRay Inc
07/02/2023	16:48	GlobeNewswire Inc.	Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.	AMEX:ISR	IsoRay Inc